Pathology/Lab Coding Alert

ICD-10 Sidebar:

600 to N40: Expect Fewer Enlarged Prostate Code Choices

Cyst moves to different family. When you start getting test orders under ICD-10 with enlarged prostate as the ordering diagnosis, you can say goodbye to benign prostatic hypertrophy (BPH). That's because the new code set streamlines enlarged prostate coding by collapsing eight codes into four. Although CMS has postponed the ICD-10 implementation date from Oct. 1, 2013, your lab should continue to prepare for the eventual change, now unofficially anticipated for Oct. 1, 2014. Make 'Hypertrophy' Simple BPH (600.0x, Hypertrophy [benign] of prostate) may be the ordering diagnosis when your lab performs a prostate specific antigen (PSA) test 84153 (Prostate specific antigen [PSA]; total) or perhaps a prostate biopsy (such as 88305, Level IV - Surgical pathology, gross and microscopic examination; prostate, needle biopsy). But you won't see the term 'BPH' once ICD-10 goes into effect, because the new code set collapses ICD-9 terminology "hypertrophy (benign) of prostate," "benign localized [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All